Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic Alterations.

JAMA network open - 2 Aug 2021

Leiva Orly, Baker Olesya, Jenkins Andrew, Brunner Andrew M, Al-Samkari Hanny, Leaf Rebecca Karp, Rosovsky Rachel P, Fathi Amir T, Weitzman James, Bornikova Larissa, Nardi Valentina, Hobbs Gabriela S

Abstract excerpt

Importance: Hypereosinophilic syndromes (HESs) are a rare group of disorders that result in overproduction of eosinophils, leading to tissue damage. Thrombotic complications in HES and associated risk factors in this patient population have not been extensively studied. Objective: To investigate the rates of and risk factors associated with thrombotic events in patients with HES, including markers of clonal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Venous Thrombosis
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Boston

Share to Cause of Death

Share to Cohort Studies

Share to Hypereosinophilic Syndrome

Share to Mortality

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 34357393
DOI: 10.1001/jamanetworkopen.2021.19812
PMCID: PMC8346937

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic Alterations.PMID 34357393Read ↗

Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

One thousand patients with essential thrombocythemia: the Mayo Clinic experience.Semantic proximity Read ↗

Essential thrombocythemia: a hemostatic view of thrombogenic risk factors and prognosis.Semantic proximity Read ↗

Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.Semantic proximity Read ↗

Clinical course of myeloproliferative leukaemia virus oncogene (MPL) mutation-associated familial thrombocytosis: a review of 64 paediatric and adult patients.Semantic proximity Read ↗

Thrombotic Prediction Model Based on Epigenetic Regulator Mutations in Essential Thrombocythemia Patients Using Survival Analysis in Recurrent Events.Semantic proximity Read ↗

Reduced Platelet Activation in Triple-Negative Essential Thrombocythemia Compared with JAK2V617F-Mutated Essential Thrombocythemia.Semantic proximity Read ↗

Incidence rates and risk factors for vascular events in patients with essential thrombocythemia: a multicenter study from Korea.Semantic proximity Read ↗

Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemiaSemantic proximity Read ↗

Essential Thrombocythemia: One-Center Data in a Changing Disease.Semantic proximity Read ↗

Essential thrombocythemia.Semantic proximity Read ↗

Thrombosis Risk Assessment in Patients with Congenital Thrombophilia During COVID-19 InfectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.